Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately ...
The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...
New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.
In addition to the DTA Fibrosis Score, VIDA’s ILD offering enables the following trial services: • Enhanced eligibility assessments, supported by novel, patented visualizations, including Tomographic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results